NO970406L - Substituerte diaryldikarboksylsyre-diguanidiner, fremgangsmåte for deres fremstilling og deres anvendelse som medikamenter eller diagnostikum såvel som medikamenter inneholdende dem - Google Patents
Substituerte diaryldikarboksylsyre-diguanidiner, fremgangsmåte for deres fremstilling og deres anvendelse som medikamenter eller diagnostikum såvel som medikamenter inneholdende demInfo
- Publication number
- NO970406L NO970406L NO970406A NO970406A NO970406L NO 970406 L NO970406 L NO 970406L NO 970406 A NO970406 A NO 970406A NO 970406 A NO970406 A NO 970406A NO 970406 L NO970406 L NO 970406L
- Authority
- NO
- Norway
- Prior art keywords
- residues
- atoms
- hydrogen
- alkyl
- well
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 4
- 239000002253 acid Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 206010061216 Infarction Diseases 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 230000007574 infarction Effects 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000003293 cardioprotective effect Effects 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 230000035778 pathophysiological process Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/60—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19603425A DE19603425A1 (de) | 1996-01-31 | 1996-01-31 | Substituierte Diaryldicarbonsäure-diguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO970406D0 NO970406D0 (no) | 1997-01-30 |
| NO970406L true NO970406L (no) | 1997-08-01 |
Family
ID=7784136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO970406A NO970406L (no) | 1996-01-31 | 1997-01-30 | Substituerte diaryldikarboksylsyre-diguanidiner, fremgangsmåte for deres fremstilling og deres anvendelse som medikamenter eller diagnostikum såvel som medikamenter inneholdende dem |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0787717A1 (cs) |
| JP (1) | JPH09221465A (cs) |
| KR (1) | KR970059165A (cs) |
| AR (1) | AR005596A1 (cs) |
| AU (1) | AU1239097A (cs) |
| BR (1) | BR9700817A (cs) |
| CA (1) | CA2196388A1 (cs) |
| CZ (1) | CZ27197A3 (cs) |
| DE (1) | DE19603425A1 (cs) |
| HR (1) | HRP970057A2 (cs) |
| HU (1) | HUP9700277A3 (cs) |
| IL (1) | IL120093A0 (cs) |
| NO (1) | NO970406L (cs) |
| NZ (1) | NZ314145A (cs) |
| PL (1) | PL317844A1 (cs) |
| SK (1) | SK12797A3 (cs) |
| TR (1) | TR199700059A2 (cs) |
| TW (1) | TW430642B (cs) |
| ZA (1) | ZA97770B (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10024319A1 (de) * | 2000-05-17 | 2001-11-22 | Merck Patent Gmbh | Bisacylguanidine |
| AR065785A1 (es) * | 2007-03-19 | 2009-07-01 | Xenon Pharmaceuticals Inc | Compuestos biarilo y biheteroarilo de utilidad en el tratamiento de trastornos de hierro |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3929582A1 (de) | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
| ATE139526T1 (de) | 1992-02-15 | 1996-07-15 | Hoechst Ag | 3,5-substituierte benzoylguanidine, mit antiarrythmischer wirkung und inhibierender wirkung auf die proliferationen von zellen |
| US5278933A (en) | 1992-06-30 | 1994-01-11 | Hunsinger Terrance D | Fiber optic splice organizer and associated method |
| EP0604852A1 (de) * | 1992-12-28 | 1994-07-06 | Hoechst Aktiengesellschaft | 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters |
| IL109570A0 (en) * | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
| DE4327244A1 (de) * | 1993-08-13 | 1995-02-16 | Hoechst Ag | Harnstoffsubstituierte Benzoylguandine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1996
- 1996-01-31 DE DE19603425A patent/DE19603425A1/de not_active Withdrawn
-
1997
- 1997-01-08 PL PL97317844A patent/PL317844A1/xx unknown
- 1997-01-20 EP EP97100776A patent/EP0787717A1/de not_active Withdrawn
- 1997-01-29 SK SK127-97A patent/SK12797A3/sk unknown
- 1997-01-29 TW TW086100957A patent/TW430642B/zh active
- 1997-01-29 IL IL12009397A patent/IL120093A0/xx unknown
- 1997-01-29 NZ NZ314145A patent/NZ314145A/en unknown
- 1997-01-29 HU HU9700277A patent/HUP9700277A3/hu unknown
- 1997-01-29 AR ARP970100360A patent/AR005596A1/es unknown
- 1997-01-29 CZ CZ97271A patent/CZ27197A3/cs unknown
- 1997-01-29 AU AU12390/97A patent/AU1239097A/en not_active Abandoned
- 1997-01-29 TR TR97/00059A patent/TR199700059A2/xx unknown
- 1997-01-30 ZA ZA97770A patent/ZA97770B/xx unknown
- 1997-01-30 CA CA002196388A patent/CA2196388A1/en not_active Abandoned
- 1997-01-30 BR BR9700817A patent/BR9700817A/pt not_active Application Discontinuation
- 1997-01-30 HR HR19603425.6A patent/HRP970057A2/hr not_active Application Discontinuation
- 1997-01-30 JP JP9016046A patent/JPH09221465A/ja active Pending
- 1997-01-30 NO NO970406A patent/NO970406L/no unknown
- 1997-01-31 KR KR1019970003012A patent/KR970059165A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9700277A3 (en) | 1998-04-28 |
| CZ27197A3 (cs) | 1998-05-13 |
| CA2196388A1 (en) | 1997-08-01 |
| HU9700277D0 (en) | 1997-03-28 |
| JPH09221465A (ja) | 1997-08-26 |
| DE19603425A1 (de) | 1997-08-07 |
| TR199700059A2 (tr) | 1997-08-21 |
| KR970059165A (ko) | 1997-08-12 |
| HUP9700277A2 (en) | 1997-10-28 |
| PL317844A1 (en) | 1997-08-04 |
| AR005596A1 (es) | 1999-06-23 |
| SK12797A3 (en) | 1998-02-04 |
| EP0787717A1 (de) | 1997-08-06 |
| TW430642B (en) | 2001-04-21 |
| NZ314145A (en) | 1997-11-24 |
| NO970406D0 (no) | 1997-01-30 |
| AU1239097A (en) | 1997-08-07 |
| IL120093A0 (en) | 1997-04-15 |
| HRP970057A2 (en) | 1998-04-30 |
| BR9700817A (pt) | 1998-07-07 |
| ZA97770B (en) | 1997-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2090063A1 (en) | Surfactant composition and method of making same | |
| CA2066640A1 (en) | Heterocyclic compounds | |
| NO179868C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive kondenserte heterocykliske forbindelser | |
| NO903941L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater. | |
| GR3024927T3 (en) | Substituted benzoylguanidines, process for their preparation, their use as medicaments as well as medicament containing them. | |
| IL110625A0 (en) | Urea-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical compositions containing them | |
| NO970406L (no) | Substituerte diaryldikarboksylsyre-diguanidiner, fremgangsmåte for deres fremstilling og deres anvendelse som medikamenter eller diagnostikum såvel som medikamenter inneholdende dem | |
| PL118755B1 (en) | Process for preparing novel derivatives of phenethanolamine | |
| SE8406302D0 (sv) | New aminoguanidine derivatives and a process for the preparation thereof | |
| CA2395410A1 (en) | Triazolotriazinones and the use thereof | |
| HUT62563A (en) | Process for producing 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydroproin derivatives and pharmaceutical compositions comprising same | |
| BR9910628A (pt) | Uso de um composto da série da benzofuroxana, composição farmacêutica, e, processos para a preparação de uma formulação parenteral e para o tratamento de um mamìfero, incluindo um ser humano, de doenças cardìacas da coronária | |
| PL317154A1 (en) | Novel derivatives of hydroxamic acid, pharmaceutic compositions containing them and process for obtaining such derivatives | |
| DE2965292D1 (en) | Isatin derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | |
| MX9602841A (es) | Benzoilguanidinas sustituidas con fluoroalquilo en la posicion 4, un procedimiento para su preparacion, su utilizacion como medicamento o agente diagnostico, asi como un medicamento que las contiene. | |
| KR980002019A (ko) | 오르토-치환된 벤조일구아니딘, 이의 제법, 약제 또는 진단제로서의 이의 용도 및 이를 포함하는 약제 | |
| US4587359A (en) | Amine-carbamoylborane adducts | |
| US3681441A (en) | Quaternary fluorinated ammonium salts | |
| ATE183498T1 (de) | Substituierte indenoylguanidines mit antiarrhythmischer und cardioprotektiver wirkung | |
| NO964905L (no) | Substituerte benzendikarboksylsyre-diguanidider, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen | |
| Saari et al. | The stereoisomers of. alpha.-(1-aminoethyl)-m-hydroxybenzyl alcohol | |
| CA2206362A1 (en) | Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them | |
| MX9605538A (es) | Benzoil-guanidinas sustituidas con sulfonilamino, procedimiento para su preparacion, su empleo como medicamento o para diagnostico, asi como el medicamento que las contiene. | |
| GB872997A (en) | Substituted ún-aminoalkoxy-acyl benzenes and processes for their manufacture | |
| ID16173A (id) | Proses kimia |